关注
Ibrahim Halil Tanboga, MD, PhD
Ibrahim Halil Tanboga, MD, PhD
Nisantasi University Medical School, Departments of Biostatistics and Cardiology
在 nisantasi.edu.tr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome
E Buyukkaya, MF Karakaş, E Karakaş, AB Akçay, IH Tanboga, M Kurt, ...
Clinical and applied thrombosis/hemostasis 20 (2), 159-163, 2014
2312014
Relation of red cell distribution width with the presence, severity, and complexity of coronary artery disease
T Isik, H Uyarel, IH Tanboga, M Kurt, M Ekinci, A Kaya, E Ayhan, ...
Coronary artery disease 23 (1), 51-56, 2012
1342012
Relation of left ventricular end-diastolic pressure and N-terminal pro-brain natriuretic peptide level with left atrial deformation parameters
M Kurt, IH Tanboga, E Aksakal, A Kaya, T Isik, M Ekinci, E Bilen
European Heart Journal–Cardiovascular Imaging 13 (6), 524-530, 2012
972012
Assessment of relationship between C-reactive protein to albumin ratio and coronary artery disease severity in patients with acute coronary syndrome
M Çağdaş, I Rencüzoğullari, S Karakoyun, Y Karabağ, M Yesin, I Artaç, ...
Angiology 70 (4), 361-368, 2019
952019
Increased right ventricular glucose metabolism in patients with pulmonary arterial hypertension
MM Can, C Kaymaz, IH Tanboga, HC Tokgoz, N Canpolat, E Turkyilmaz, ...
Clinical nuclear medicine 36 (9), 743-748, 2011
852011
Neutrophil-to-lymphocyte ratio predicts contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention
A Kaya, Y Kaya, S Topçu, ZY Günaydın, M Kurt, IH Tanboğa, K Kalkan, ...
Angiology 65 (1), 51-56, 2014
842014
Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial
M Biteker, NE Duran, H Kaya, S Gündüz, Hİ Tanboğa, T Gökdeniz, ...
Clinical Research in Cardiology 100, 571-577, 2011
832011
Prognostic efficacy of C-reactive protein/albumin ratio in ST elevation myocardial infarction
T Çınar, M Çağdaş, İ Rencüzoğulları, S Karakoyun, Y Karabağ, M Yesin, ...
Scandinavian Cardiovascular Journal 53 (2), 83-90, 2019
812019
Determinants of angiographic thrombus burden in patients with ST-segment elevation myocardial infarction
IH Tanboga, S Topcu, E Aksakal, K Kalkan, S Sevimli, M Acikel
Clinical and Applied Thrombosis/Hemostasis 20 (7), 716-722, 2014
802014
Relation of neutrophil to lymphocyte ratio with the presence and severity of stable coronary artery disease
A Kaya, M Kurt, IH Tanboga, T Işık, ZY Günaydın, Y Kaya, S Topçu, ...
Clinical and Applied Thrombosis/Hemostasis 20 (5), 473-477, 2014
792014
The role of frailty on adverse outcomes among older patients with COVID-19
H Kundi, EHÖ Çetin, U Canpolat, S Aras, O Celik, N Ata, S Birinci, S Cay, ...
Journal of Infection 81 (6), 944-951, 2020
742020
Relationship between C‐reactive protein/albumin ratio and coronary artery disease severity in patients with stable angina pectoris
Y Karabağ, M Çağdaş, I Rencuzogullari, S Karakoyun, İ Artaç, D İliş, ...
Journal of clinical laboratory analysis 32 (7), e22457, 2018
742018
The impact of admission red cell distribution width on the development of poor myocardial perfusion after primary percutaneous intervention
T Isik, M Kurt, E Ayhan, IH Tanboga, M Ergelen, H Uyarel
Atherosclerosis 224 (1), 143-149, 2012
702012
The relation of serum gamma-glutamyl transferase levels with coronary lesion complexity and long-term outcome in patients with stable coronary artery disease
E Aksakal, IH Tanboga, M Kurt, MA Kaygın, A Kaya, T Isik, M Ekinci, ...
Atherosclerosis 221 (2), 596-601, 2012
692012
Usefulness of the C‐reactive protein/albumin ratio for predicting no‐reflow in ST‐elevation myocardial infarction treated with primary percutaneous coronary intervention
Y Karabağ, M Çağdaş, I Rencuzogullari, S Karakoyun, İ Artaç, D İliş, ...
European journal of clinical investigation 48 (6), e12928, 2018
672018
The role of the nonspecific inflammatory markers in determining the anatomic extent of venous thromboembolism
EM Bakirci, S Topcu, K Kalkan, IH Tanboga, A Borekci, S Sevimli, ...
Clinical and Applied Thrombosis/Hemostasis 21 (2), 181-185, 2015
652015
Reproducibility of syntax score: from core lab to real world
IH Tanboga, M Ekinci, T Isik, M Kurt, A Kaya, S Sevimli
Journal of interventional cardiology 24 (4), 302-306, 2011
592011
Association of neutrophil to lymphocyte ratio with presence of isolated coronary artery ectasia
T Işık, E Ayhan, H Uyarel, İH Tanboğa, M Kurt, M Uluganyan, M Ergelen, ...
582013
Ultrasound-assisted catheter-directed thrombolysis in high-risk and intermediate-high-risk pulmonary embolism: a meta-analysis
C Kaymaz, OY Akbal, IH Tanboga, A Hakgor, F Yilmaz, S Ozturk, N Poci, ...
Current Vascular Pharmacology 16 (2), 179-189, 2018
562018
The role of oxidative stress in diabetic cardiomyopathy: an experimental study.
E Aksakal, N Akaras, M Kurt, IH Tanboga, Z Halici, F Odabasoglu, ...
European Review for Medical & Pharmacological Sciences 15 (11), 2011
562011
系统目前无法执行此操作,请稍后再试。
文章 1–20